Back to Treatments

Treatment

Standardized Shorter MDR-TB Regimen (SSR)

1
Conditions
20
Trials
8,000
Participants
48%
Average Safety

Condition Evidence

Multidrug-resistant tuberculosis without extensive drug resistance

20 trials · 8,000 participants

75% effectiveness · 48% safety
Standardized Shorter MDR-TB Regimen (SSR) | DFDA